3rd Quarter - Report

AMERICA'S BLOOD CENTERS for AMERICA'S BLOOD CENTERS

Firm
Client
Income
—
Expenses
$10,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Patient Protection and Affordable Care Act (PL 111-148) and Health Care and Education Reconciliation Act (PL 111-152) American Recovery and Reinvestment Act (PL 111-5); National Cord Blood Inventory; FDA's ban on blood donations from men who have sex with men; FDA's recommendation to improve 510(k) approvals

LobbyistCovered position, as disclosed
ANNE ELIZABETH CARROLL —
ROBERT KAPLER —
JAMES MACPHERSON —

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Budget/Appropriations BUD

Patient Protection and Affordable Care Act (PL 111-148) and Health Care and Education Reconciliation Act (PL 111-152) American Recovery and Reinvestment Act (PL 111-5)

LobbyistCovered position, as disclosed
ANNE ELIZABETH CARROLL —
ROBERT KAPLER —
JAMES MACPHERSON —

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.